Mutamycin Alternatives Compared
| Mutamycin (mitomycin) | Gemcitabine | Fluorouracil |
|
|---|
| Mutamycin (mitomycin) | Gemcitabine | Fluorouracil |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Bladder Cancer, Pancreatic Cancer, Stomach Cancer. Mutamycin may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Pancreatic Cancer, Ovarian Cancer, Non Small Cell Lung Cancer, Breast Cancer - Metastatic, Breast Cancer, Nasopharyngeal Carcinoma. Gemcitabine may also be used for purposes not listed... View more |
Prescription only
Prescribed for Colorectal Cancer, Anal Cancer, Breast Cancer, Pancreatic Cancer, Breast Cancer - Palliative, Cancer, Cervical Cancer, Nasopharyngeal Carcinoma, Stomach Cancer. Fluorouracil may also... View more |
||||||||||||||||||||||||
| More about Mutamycin (mitomycin) | More about Gemcitabine | More about Fluorouracil | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Be the first to share your experience with this drug. |
Gemcitabine has an average rating of 8.4 out of 10 from a total of 9 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 0% reported a negative effect. |
Fluorouracil has an average rating of 4.3 out of 10 from a total of 4 ratings on Drugs.com. 25% of reviewers reported a positive effect, while 50% reported a negative effect. |
||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
|
View all Mutamycin side effects |
View all Gemcitabine side effects |
View all Fluorouracil side effects |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
N/A |
Lower cost generic |
Lower cost generic |
||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Mutamycin prices |
View all Gemcitabine prices |
View all Fluorouracil prices |
||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Other mitomycin brands include: Jelmyto, Zusduri | Avgemsi, Gemzar, Infugem |
N/A |
||||||||||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
|
2 hours |
10.5 hours |
0.33 hours |
||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category N
Not classified
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 267 drugs are known to interact with Mutamycin:
|
A total of 286 drugs are known to interact with Gemcitabine:
|
A total of 293 drugs are known to interact with Fluorouracil:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
August 24, 1981 |
May 15, 1996 |
N/A |
||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Keytruda
Keytruda is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
Adriamycin
Adriamycin is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder cancer ...
Botox
Botox is used cosmetically to reduce facial lines and wrinkles and for medical purposes for ...
Imfinzi
Imfinzi (durvalumab) is an immunotherapy used to treat types of lung cancer (NSCLC, SCLC), bile ...
Padcev
Padcev (enfortumab vedotin) is an antibody-drug conjugate that is given as an intravenous infusion ...
Balversa
Balversa (erdafitinib) is an oral kinase inhibitor that may be used to treat adults with locally ...
Anktiva
Anktiva (N-803) is used to treat specific types of bladder cancer. It is FDA-approved to be used ...
Enfortumab vedotin
Enfortumab vedotin is used for bladder cancer, urothelial carcinoma
Durvalumab
Durvalumab (Imfinzi) is an immunotherapy used to treat lung cancer (NSCLC, SCLC) and other cancers ...
Doxorubicin
Doxorubicin is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder cancer ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.